(Q38366473)

2 September 2017

1 reference

title

Red yeast rice for the treatment of dyslipidemia (English)

1 reference

2 September 2017

1 reference

Frances M Burke

1

1 reference

2 September 2017

publication date

1 April 2015

1 reference

Current Atherosclerosis Reports

2 September 2017

published in

1 reference

2 September 2017

volume

17

1 reference

2 September 2017

issue

4

1 reference

2 September 2017

page(s)

495

1 reference

https://scigraph.springernature.com/pub.10.1007/s11883-015-0495-8

2 September 2017

exact match

0 references

cites work

The role of red yeast rice for the physician

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0495-8

Is red yeast rice safe and effective for lowering serum cholesterol?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0495-8

Review of red yeast rice content and current Food and Drug Administration oversight

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0495-8

Constituents of red yeast rice, a traditional Chinese food and medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0495-8

Simvastatin vs therapeutic lifestyle changes and supplements: randomized primary prevention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0495-8

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0495-8

Role of dietary supplements in lowering low-density lipoprotein cholesterol: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0495-8

Improved dissolution rate and oral bioavailability of lovastatin in red yeast rice products.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0495-8

Efficacy and safety of Monascus purpureus Went rice in subjects with hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0495-8

Red yeast rice lowers cholesterol in physicians - a double blind, placebo controlled randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0495-8

Effects of Xuezhikang in patients with dyslipidemia: a multicenter, randomized, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0495-8

Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0495-8

Beneficial impact of Xuezhikang on cardiovascular events and mortality in elderly hypertensive patients with previous myocardial infarction from the China Coronary Secondary Prevention Study (CCSPS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0495-8

A meta-analysis of red yeast rice: an effective and relatively safe alternative approach for dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0495-8

Tolerability of red yeast rice (2,400 mg twice daily) versus pravastatin (20 mg twice daily) in patients with previous statin intolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0495-8

Red yeast rice for dyslipidemia in statin-intolerant patients: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0495-8

Phytosterols, red yeast rice, and lifestyle changes instead of statins: a randomized, double-blinded, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0495-8

Effect of plant stanol tablets on low-density lipoprotein cholesterol lowering in patients on statin drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0495-8

Lipid-lowering efficacy of red yeast rice in a population intolerant to statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0495-8

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0495-8

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0495-8

The effect of red yeast rice (Monascus purpureus) in dyslipidemia and other disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0495-8

Marked variability of monacolin levels in commercial red yeast rice products: buyer beware!

21 January 2018

1 reference

12 December 2020

Safety and efficacy of red yeast rice (Monascus purpureus) as an alternative therapy for hyperlipidemia

1 reference

12 December 2020

Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement

1 reference

12 December 2020

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

10.1007/S11883-015-0495-8

Identifiers

DOI

1 reference

Dimensions Publication ID

2 September 2017

1023995571

0 references

Fatcat ID

release_zubhlnrvg5hjbdjv4cdnn6ybqe

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zubhlnrvg5hjbdjv4cdnn6ybqe

24 November 2022

mapped directly with Wikidata item

1 reference